UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014728
Receipt number R000017115
Scientific Title Vagus Nerve Stimulation Post marketing surveillance in Japan
Date of disclosure of the study information 2014/07/31
Last modified on 2019/09/13 12:10:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Vagus Nerve Stimulation
Post marketing surveillance in Japan

Acronym

Vagus Nerve Stimulation
Post marketing surveillance in Japan

Scientific Title

Vagus Nerve Stimulation
Post marketing surveillance in Japan

Scientific Title:Acronym

Vagus Nerve Stimulation
Post marketing surveillance in Japan

Region

Japan


Condition

Condition

Refractory epilepsy

Classification by specialty

Medicine in general Neurology Pediatrics
Psychiatry Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Respond to the attached condition of marketing approval, on the basis of the provisions of Article 14-4 (re-examination of new medical device) of the Pharmaceutical Affairs Law of Japan, to value the efficacy and safety of Vagus Nerve Stimulation on Post marketing surveillance in Japan.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Lead Impedance, Infection,
Adverse Event, Seizure Frequency

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Not applicable

Key exclusion criteria

Not applicable

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Inai

Organization

NIHON KOHDEN CORPORATION

Division name

Quality Management Division

Zip code


Address

3-14-20 Higashinakano, Nakano-ku,Tokyo

TEL

03-5996-8022

Email

Takashi_Inai@mb1.nkc.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shiro Okada

Organization

NIHON KOHDEN CORPORATION

Division name

Import Business Operations

Zip code


Address

3-14-20 Higashinakano, Nakano-ku,Tokyo

TEL

03-5348-1574

Homepage URL


Email

Shiro_Okada@mb3.nkc.co.jp


Sponsor or person

Institute

NIHON KOHDEN CORPORATION

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

385

Results

DMAH(Designated Marketing Authorization Holder) for the device transferred from NIHON KOHDEN CORPORATION to other company.
This study terminated as NIHON KOHDEN CORPORATION.

Results date posted

2019 Year 09 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2010 Year 06 Month 15 Day

Date of IRB

2010 Year 07 Month 15 Day

Anticipated trial start date

2010 Year 07 Month 21 Day

Last follow-up date

2019 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2014 Year 07 Month 31 Day

Last modified on

2019 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017115


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name